A detailed history of Janus Henderson Group PLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 109,941 shares of PACB stock, worth $249,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109,941
Previous 109,941 -0.0%
Holding current value
$249,566
Previous $150,000 24.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.36 - $3.65 $1,880 - $5,047
-1,383 Reduced 1.24%
109,941 $150,000
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $168 - $460
48 Added 0.04%
111,324 $417,000
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $716 - $1,243
-120 Reduced 0.11%
111,276 $1.09 Million
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $1,111 - $1,880
135 Added 0.12%
111,396 $930,000
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $103,518 - $145,881
10,383 Added 10.29%
111,261 $1.48 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $503,967 - $762,933
63,472 Added 169.68%
100,878 $1.17 Million
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $11 - $22
-2 Reduced 0.01%
37,406 $305,000
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $86 - $188
-22 Reduced 0.06%
37,408 $218,000
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $56 - $146
-14 Reduced 0.04%
37,430 $166,000
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $109 - $271
13 Added 0.03%
37,444 $340,000
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $363,975 - $568,451
18,898 Added 101.97%
37,431 $765,000
Q3 2021

Nov 16, 2021

BUY
$24.86 - $35.02 $460,730 - $649,025
18,533 New
18,533 $474,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $510M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.